is a Contract Research Organization (CRO) serving clients with their unparalleled experience and expertise in evaluating drug candidates as substrates, inhibitors and inducers of cytochrome P450 enzymes. Based in Kansas, USA; Xenotech offers an extensive selection of products for drug metabolism research. To assess the victim and perpetrator potential of drug candidates, XenoTech also designs and conducts studies in accordance with US FDA
Dundee, Scotland is the major supplier of recombinant CYP enzymes to the world. The patented technology underlying Cypex’s products was developed at the University of Dundee, Scotland during a five year project in partnership with 15 pharmaceutical companies. It enables the expression of human drug metabolizing enzymes in bacteria without the need for large modifications to be made to the proteins.